{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:03:04Z","timestamp":1778634184362,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,4,23]],"date-time":"2014-04-23T00:00:00Z","timestamp":1398211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"},{"start":{"date-parts":[[2014,4,23]],"date-time":"2014-04-23T00:00:00Z","timestamp":1398211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep04754","type":"journal-article","created":{"date-parts":[[2014,4,23]],"date-time":"2014-04-23T09:02:00Z","timestamp":1398243720000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Reductive Methylation and Mutation of an Anthrax Toxin Fusion Protein Modulates its Stability and Cytotoxicity"],"prefix":"10.1038","volume":"4","author":[{"given":"Christopher","family":"Bachran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silke","family":"Bachran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clinton E.","family":"Leysath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Hoover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasem J.","family":"Fattah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen H.","family":"Leppla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,23]]},"reference":[{"key":"BFsrep04754_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2174\/138945009787354557","volume":"10","author":"H Fuchs","year":"2009","unstructured":"Fuchs, H. & Bachran, C. Targeted tumor therapies at a glance. Curr Drug Targets 10, 89\u201393 (2009).","journal-title":"Curr Drug Targets"},{"key":"BFsrep04754_CR2","first-page":"6061","volume":"60","author":"S Liu","year":"2000","unstructured":"Liu, S., Netzel-Arnett, S., Birkedal-Hansen, H. & Leppla, S. H. Tumor cell-selective cytotoxicity of matrix metalloproteinase-activated anthrax toxin. Cancer Res 60, 6061\u20136067 (2000).","journal-title":"Cancer Res"},{"key":"BFsrep04754_CR3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1074\/jbc.M707419200","volume":"283","author":"S Liu","year":"2008","unstructured":"Liu, S. et al. Matrix metalloproteinase-activated anthrax lethal toxin demonstrates high potency in targeting tumor vasculature. J Biol Chem 283, 529\u2013540, 10.1074\/jbc.M707419200 (2008).","journal-title":"J Biol Chem"},{"key":"BFsrep04754_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1006\/prep.2000.1208","volume":"18","author":"S Park","year":"2000","unstructured":"Park, S. & Leppla, S. H. Optimized production and purification of Bacillus anthracis lethal factor. Protein Expr Purif 18, 293\u2013302, 10.1006\/prep.2000.1208 (2000).","journal-title":"Protein Expr Purif"},{"key":"BFsrep04754_CR5","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1182\/blood-2004-01-0339","volume":"104","author":"RJ Abi-Habib","year":"2004","unstructured":"Abi-Habib, R. J., Liu, S., Bugge, T. H., Leppla, S. H. & Frankel, A. E. A urokinase-activated recombinant diphtheria toxin targeting the granulocyte-macrophage colony-stimulating factor receptor is selectively cytotoxic to human acute myeloid leukemia blasts. Blood 104, 2143\u20132148, 10.1182\/blood-2004-01-0339 (2004).","journal-title":"Blood"},{"key":"BFsrep04754_CR6","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1093\/emboj\/19.1.94","volume":"19","author":"JS Thrower","year":"2000","unstructured":"Thrower, J. S., Hoffman, L., Rechsteiner, M. & Pickart, C. M. Recognition of the polyubiquitin proteolytic signal. EMBO J 19, 94\u2013102, 10.1093\/emboj\/19.1.94 (2000).","journal-title":"EMBO J"},{"key":"BFsrep04754_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1126\/science.3018930","volume":"234","author":"A Bachmair","year":"1986","unstructured":"Bachmair, A., Finley, D. & Varshavsky, A. In vivo half-life of a protein is a function of its amino-terminal residue. Science 234, 179\u2013186 (1986).","journal-title":"Science"},{"key":"BFsrep04754_CR8","doi-asserted-by":"crossref","unstructured":"Varshavsky, A. The N-end rule pathway and regulation by proteolysis. Protein Sci 10.1002\/pro.666 (2011).","DOI":"10.1002\/pro.666"},{"key":"BFsrep04754_CR9","doi-asserted-by":"publisher","first-page":"e3130","DOI":"10.1371\/journal.pone.0003130","volume":"3","author":"PK Gupta","year":"2008","unstructured":"Gupta, P. K., Moayeri, M., Crown, D., Fattah, R. J. & Leppla, S. H. Role of N-terminal amino acids in the potency of anthrax lethal factor. PLoS One 3, e3130, 10.1371\/journal.pone.0003130 (2008).","journal-title":"PLoS One"},{"key":"BFsrep04754_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0076-6879(97)76058-0","volume":"276","author":"I Rayment","year":"1997","unstructured":"Rayment, I. Reductive alkylation of lysine residues to alter crystallization properties of proteins. Methods Enzymol 276, 171\u2013179 (1997).","journal-title":"Methods Enzymol"},{"key":"BFsrep04754_CR11","doi-asserted-by":"publisher","first-page":"e74474","DOI":"10.1371\/journal.pone.0074474","volume":"8","author":"CE Leysath","year":"2013","unstructured":"Leysath, C. E. et al. Anthrax edema factor toxicity is strongly mediated by the N-end rule. PLoS One 8, e74474, 10.1371\/journal.pone.0074474 (2013).","journal-title":"PLoS One"},{"key":"BFsrep04754_CR12","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.2174\/138161209788923930","volume":"15","author":"C Hetzel","year":"2009","unstructured":"Hetzel, C., Bachran, C., Tur, M. K., Fuchs, H. & Stocker, M. Improved immunotoxins with novel functional elements. Curr Pharm Des 15, 2700\u20132711 (2009).","journal-title":"Curr Pharm Des"},{"key":"BFsrep04754_CR13","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1177\/153537020623100407","volume":"231","author":"C Bachran","year":"2006","unstructured":"Bachran, C. et al. The saponin-mediated enhanced uptake of targeted saporin-based drugs is strongly dependent on the saponin structure. Exp Biol Med (Maywood) 231, 412\u2013420 (2006).","journal-title":"Exp Biol Med (Maywood)"},{"key":"BFsrep04754_CR14","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2005.09.095","volume":"337","author":"C Bachran","year":"2005","unstructured":"Bachran, C., Heisler, I., Fuchs, H. & Sutherland, M. Influence of protein transduction domains on target-specific chimeric proteins. Biochem Biophys Res Commun 337, 602\u2013609, 10.1016\/j.bbrc.2005.09.095 (2005).","journal-title":"Biochem Biophys Res Commun"},{"key":"BFsrep04754_CR15","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.1182\/blood-2008-08-173195","volume":"113","author":"JE Weldon","year":"2009","unstructured":"Weldon, J. E. et al. A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity. Blood 113, 3792\u20133800, 10.1182\/blood-2008-08-173195 (2009).","journal-title":"Blood"},{"key":"BFsrep04754_CR16","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0006-291X(89)91660-4","volume":"160","author":"E London","year":"1989","unstructured":"London, E. & Luongo, C. L. Domain-specific bias in arginine\/lysine usage by protein toxins. Biochem Biophys Res Commun 160, 333\u2013339 (1989).","journal-title":"Biochem Biophys Res Commun"},{"key":"BFsrep04754_CR17","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.1074\/jbc.275.6.4363","volume":"275","author":"PO Falnes","year":"2000","unstructured":"Falnes, P. O., Ariansen, S., Sandvig, K. & Olsnes, S. Requirement for prolonged action in the cytosol for optimal protein synthesis inhibition by diphtheria toxin. J Biol Chem 275, 4363\u20134368 (2000).","journal-title":"J Biol Chem"},{"key":"BFsrep04754_CR18","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1158\/0008-5472.CAN-06-4642","volume":"67","author":"Y Su","year":"2007","unstructured":"Su, Y. et al. Systematic urokinase-activated anthrax toxin therapy produces regressions of subcutaneous human non-small cell lung tumor in athymic nude mice. Cancer Res 67, 3329\u20133336, 10.1158\/0008-5472.CAN-06-4642 (2007).","journal-title":"Cancer Res"},{"key":"BFsrep04754_CR19","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1158\/1535-7163.MCT-06-0315","volume":"5","author":"RJ Abi-Habib","year":"2006","unstructured":"Abi-Habib, R. J. et al. A urokinase-activated recombinant anthrax toxin is selectively cytotoxic to many human tumor cell types. Mol Cancer Ther 5, 2556\u20132562, 10.1158\/1535-7163.MCT-06-0315 (2006).","journal-title":"Mol Cancer Ther"},{"key":"BFsrep04754_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10969-010-9079-6","volume":"11","author":"Y Fan","year":"2010","unstructured":"Fan, Y. & Joachimiak, A. Enhanced crystal packing due to solvent reorganization through reductive methylation of lysine residues in oxidoreductase from Streptococcus pneumoniae. J Struct Funct Genomics 11, 101\u2013111, 10.1007\/s10969-010-9079-6 (2010).","journal-title":"J Struct Funct Genomics"},{"key":"BFsrep04754_CR21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s10858-009-9306-2","volume":"43","author":"SJ Abraham","year":"2009","unstructured":"Abraham, S. J., Kobayashi, T., Solaro, R. J. & Gaponenko, V. Differences in lysine pKa values may be used to improve NMR signal dispersion in reductively methylated proteins. J Biomol NMR 43, 239\u2013246, 10.1007\/s10858-009-9306-2 (2009).","journal-title":"J Biomol NMR"},{"key":"BFsrep04754_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1006\/jmbi.1996.0234","volume":"258","author":"IA Taylor","year":"1996","unstructured":"Taylor, I. A., Webb, M. & Kneale, G. G. Surface labelling of the type I methyltransferase M.EcoR124I reveals lysine residues critical for DNA binding. J Mol Biol 258, 62\u201373, 10.1006\/jmbi.1996.0234 (1996).","journal-title":"J Mol Biol"},{"key":"BFsrep04754_CR23","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.cbi.2009.07.007","volume":"181","author":"A Weng","year":"2009","unstructured":"Weng, A. et al. Enhancement of saporin cytotoxicity by Gypsophila saponins--more than stimulation of endocytosis. Chem Biol Interact 181, 424\u2013429, 10.1016\/j.cbi.2009.07.007 (2009).","journal-title":"Chem Biol Interact"},{"key":"BFsrep04754_CR24","doi-asserted-by":"publisher","first-page":"11782","DOI":"10.1073\/pnas.1209292109","volume":"109","author":"W Liu","year":"2012","unstructured":"Liu, W. et al. Recombinant immunotoxin engineered for low immunogenicity and antigenicity by identifying and silencing human B-cell epitopes. Proc Natl Acad Sci U S A 109, 11782\u201311787, 10.1073\/pnas.1209292109 (2012).","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFsrep04754_CR25","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nbt800","volume":"21","author":"JE Smallshaw","year":"2003","unstructured":"Smallshaw, J. E. et al. Genetic engineering of an immunotoxin to eliminate pulmonary vascular leak in mice. Nat Biotechnol 21, 387\u2013391, 10.1038\/nbt800 (2003).","journal-title":"Nat Biotechnol"},{"key":"BFsrep04754_CR26","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/j.1365-2958.2011.07614.x","volume":"80","author":"KL Thoren","year":"2011","unstructured":"Thoren, K. L. & Krantz, B. A. The unfolding story of anthrax toxin translocation. Mol Microbiol 80, 588\u2013595, 10.1111\/j.1365-2958.2011.07614.x (2011).","journal-title":"Mol Microbiol"},{"key":"BFsrep04754_CR27","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1002\/anie.201006460","volume":"50","author":"BL Pentelute","year":"2011","unstructured":"Pentelute, B. L., Sharma, O. & Collier, R. J. Chemical dissection of protein translocation through the anthrax toxin pore. Angew Chem Int Ed Engl 50, 2294\u20132296, 10.1002\/anie.201006460 (2011).","journal-title":"Angew Chem Int Ed Engl"},{"key":"BFsrep04754_CR28","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/j.1365-2958.1995.tb02375.x","volume":"15","author":"JC Milne","year":"1995","unstructured":"Milne, J. C., Blanke, S. R., Hanna, P. C. & Collier, R. J. Protective antigen-binding domain of anthrax lethal factor mediates translocation of a heterologous protein fused to its amino- or carboxy-terminus. Mol Microbiol 15, 661\u2013666 (1995).","journal-title":"Mol Microbiol"},{"key":"BFsrep04754_CR29","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1128\/iai.62.11.4955-4961.1994","volume":"62","author":"N Arora","year":"1994","unstructured":"Arora, N. & Leppla, S. H. Fusions of anthrax toxin lethal factor with shiga toxin and diphtheria toxin enzymatic domains are toxic to mammalian cells. Infect Immun 62, 4955\u20134961 (1994).","journal-title":"Infect Immun"},{"key":"BFsrep04754_CR30","doi-asserted-by":"publisher","first-page":"15737","DOI":"10.1021\/bi981436i","volume":"37","author":"J Wesche","year":"1998","unstructured":"Wesche, J., Elliott, J. L., Falnes, P. O., Olsnes, S. & Collier, R. J. Characterization of membrane translocation by anthrax protective antigen. Biochemistry 37, 15737\u201315746, 10.1021\/bi981436i (1998).","journal-title":"Biochemistry"},{"key":"BFsrep04754_CR31","doi-asserted-by":"crossref","first-page":"29039","DOI":"10.1016\/S0021-9258(19)62010-7","volume":"269","author":"Y Singh","year":"1994","unstructured":"Singh, Y., Klimpel, K. R., Arora, N., Sharma, M. & Leppla, S. H. The chymotrypsin-sensitive site, FFD315, in anthrax toxin protective antigen is required for translocation of lethal factor. J Biol Chem 269, 29039\u201329046 (1994).","journal-title":"J Biol Chem"},{"key":"BFsrep04754_CR32","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/j.1462-5822.2006.00845.x","volume":"9","author":"S Liu","year":"2007","unstructured":"Liu, S., Leung, H. J. & Leppla, S. H. Characterization of the interaction between anthrax toxin and its cellular receptors. Cell Microbiol 9, 977\u2013987, 10.1111\/j.1462-5822.2006.00845.x (2007).","journal-title":"Cell Microbiol"},{"key":"BFsrep04754_CR33","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1373\/clinchem.2007.085365","volume":"53","author":"C Bachran","year":"2007","unstructured":"Bachran, C., Sutherland, M., Bachran, D. & Fuchs, H. Quantification of diphtheria toxin mediated ADP-ribosylation in a solid-phase assay. Clin Chem 53, 1676\u20131683, 10.1373\/clinchem.2007.085365 (2007).","journal-title":"Clin Chem"},{"key":"BFsrep04754_CR34","doi-asserted-by":"publisher","first-page":"4327","DOI":"10.1128\/IAI.00730-09","volume":"77","author":"ZL Newman","year":"2009","unstructured":"Newman, Z. L., Leppla, S. H. & Moayeri, M. CA-074Me protection against anthrax lethal toxin. Infect Immun 77, 4327\u20134336, 10.1128\/IAI.00730-09 (2009).","journal-title":"Infect Immun"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep04754.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep04754","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep04754.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T07:37:04Z","timestamp":1672990624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep04754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,23]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,12,17]]}},"alternative-id":["BFsrep04754"],"URL":"https:\/\/doi.org\/10.1038\/srep04754","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,23]]},"assertion":[{"value":"18 December 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4754"}}